Appareil pulmonaire AMG20190294 A Non-interventional Biomarker Study on the;Molecular Evaluation of Archival Tumor Tissue in;Subjects with Non-Small Cell Lung Cancer;(NSCLC) Paris NICOLAS GIRARD
Appareil pulmonaire GeoMETry-III (CINC280A2301) A phase III, randomized, controlled, open-label, multicenter,;global study of capmatinib versus SoC docetaxel;chemotherapy in previously treated patients with EGFR wt,;ALK negative, locally advanced or metastatic (stage IIIB/IIIC;or IV) NSCLC harboring MET exon 14 skipping mutation;(METÀex14) Paris CATHERINE DANIEL
Sein métastatique HER2+ HER2CLIMB02 (SGNTUC-016) A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer Paris
Appareil pulmonaire MS200647-0005 A Multicenter, Double Blind, Randomized,Controlled Study of M7824 with Concurrent Chemoradiation Followed by M7824 versus Concurrent Chemoradiation Plus Placebo Followed by Durvalumab in Participants with Unresectable Stage III Non-small Cell Lung Cancer· Protocol MS200647-0005 Paris CATHERINE DANIEL
VADS TrilynX (Debio 1143-SCCHN-301) A randomized, double-blind placebo-controlled, Phase 3 study of Debio 1143 in;combination with platinum-based chemotherapy and standard fractionation intensitymodulated;radiotherapy in patients with locally advanced squamous cell carcinoma of;the head and neck, suitable for definitive chemoradiotherapy (TrilynX). Paris CHRISTOPHE LE TOURNEAU
Appareil pulmonaire AMG 20190009_25004 A Phase 3 Multicenter, Randomized, Open;Label, Active-controlled, Study of AMG 510;Versus Docetaxel for the Treatment of Previously;Treated Locally Advanced and Unresectable or;Metastatic NSCLC Subjects With Mutated;KRAS p.G12C Paris NICOLAS GIRARD
VADS M19-894 A Phase 1b, Multicenter, Open-Label Study to Determine the Safety, Tolerability,;Pharmacokinetics, and Preliminary Efficacy of ABBV-368 plus Tilsotolimod and Other Therapy;Combinations in Subjects with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Paris CHRISTOPHE LE TOURNEAU
Appareil pulmonaire NIVOTHYM (EORTC-1525) Single-arm, Multicentre, Phase II Study of Immunotherapy in Patients With Type B3 Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy Paris NICOLAS GIRARD
Appareil pulmonaire PAPILLON (61186372NSC3001 ) A Randomized, Open-label Phase 3 Study of Combination Amivantamab and;Carboplatin-Pemetrexed Therapy, Compared with Carboplatin-Pemetrexed, in Patients;with EGFR Exon 20ins Mutated Locally Advanced or Metastatic Non-Small Cell Lung;Cancer Paris NICOLAS GIRARD
Appareil pulmonaire SAVANNAH (D5084C00007) Phase II, Single Arm Study Assessing the Efficacy of Osimertinib in;Combination with Savolitinib in Patients with EGFRm+ and MET+, Locally;Advanced or Metastatic Non-Small Cell Lung Cancer who have Progressed;Following Treatment with Osimertinib (The SAVANNAH Study) Paris NICOLAS GIRARD